A pill offers a familiar and potentially more acceptable format for a broader patient population
Cautionary Note Regarding Forward-Looking Statements This communication includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended
A phase 2, adaptive randomized, double-blind, placebo-controlled, multicenter, 52-week study of HM15211 in patients with biopsy-confirmed non-alcoholic steatohepatitis - study design and rationale of HM-TRIA-201 study
Individual results vary substantially
mimics endogenous GH cycles
Overview Retatrutide is a synthetic peptide investigated in laboratory research for its ability to engage three distinct metabolic signaling pathways: glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon receptors